Apollo embraces new model with Patient Square’s investment, taking bundle of programs forward from U.K. JV roots

Five and a half years after three pharmas and three U.K. universities launched Apollo to advance a series of preclinical programs, Patient Square Capital is taking a controlling interest in the company and establishing a U.S. presence to expand the business and develop its pipeline.

Patient Square, the healthcare investment firm launched last year by KKR veteran Jim Momtazee, led a syndicate that has backed Apollo Therapeutics with $145 million, positioning the company for its next phase of growth. Joining the firm are Rock Springs Capital, Reimagined Ventures and UCL Technology Fund...